Copyright
©The Author(s) 2017.
World J Gastrointest Endosc. Sep 16, 2017; 9(9): 471-479
Published online Sep 16, 2017. doi: 10.4253/wjge.v9.i9.471
Published online Sep 16, 2017. doi: 10.4253/wjge.v9.i9.471
Variable | Type of analgesia/sedation | ||
Midazolam ± opioid | Entonox ± opioid | Unmedicated | |
Gender | |||
Female (% of females) | 6753 (76.0%) | 1609 (18.1%) | 520 (5.9%) |
Male (% of males) | 4613 (56.1%) | 2239 (27.2%) | 1373 (16.7%) |
Median age/yr (IQR) | 61.1 (50.7-70.1) | 60.4 (50.8-69.1) | 63.8 (54.3-71.4) |
Median midazolam dose/mg (IQR) | 2.5 (2.0-3.0) | ||
Opioid, mcg | |||
Number (%) given fentanyl | 10255 (90.2%) | 258 (6.7%) | 0 (0.0%) |
Number (%) given pethidine | 1060 (9.3%) | 27 (0.7%) | 0 (0.0%) |
Total number (%) given an opioid | 11299 (99.4%) | 284 (7.4%) | 0 (0.0%) |
Median fentanyl equivalent dose (IQR) | 75.0 (50.0-100.0) | 75.0 (50.0-100.0) |
Variable1 | No. with moderate-to-extreme discomfort (%)2 | Odds ratio (95%CI)1 | P value1 |
Sedation type | |||
Midazolam ± opioid | 2137 (18.8) | Reference | |
Entonox ± opioid | 689 (17.9) | 1.06 (0.95-1.18) | 0.27 |
Unmedicated | 215 (11.4) | 0.71 (0.60-0.83) | < 0.001 |
Age | 1.00 (1.00-1.01) | 0.08 | |
Gender | |||
Female | 2114 (23.9) | Reference | |
Male | 927 (11.3) | 0.40 (0.36-0.43) | < 0.001 |
Variable1 | Caecal intubation rate, n (%)2 | Odds ratio (95%CI)1 | P value1 |
Sedation type | |||
Midazolam ± opioid | 10562 (93.7) | Reference | |
Entonox ± opioid | 3612 (94.4) | 1.08 (0.92-1.28) | 0.34 |
Unmedicated | 1763 (94.2) | 0.98 (0.79-1.22) | 0.87 |
Age | 0.98 (0.97-0.98) | < 0.001 | |
Gender | |||
Female | 8159 (92.7) | Reference | |
Male | 7778 (95.3) | 1.61 (1.41-1.85) | < 0.001 |
- Citation: Robertson AR, Kennedy NA, Robertson JA, Church NI, Noble CL. Colonoscopy quality with Entonox®vs intravenous conscious sedation: 18608 colonoscopy retrospective study. World J Gastrointest Endosc 2017; 9(9): 471-479
- URL: https://www.wjgnet.com/1948-5190/full/v9/i9/471.htm
- DOI: https://dx.doi.org/10.4253/wjge.v9.i9.471